Literature DB >> 30449013

Nitroxoline: an option for the treatment of urinary tract infection with multi-resistant uropathogenic bacteria.

Herbert Hof1, C Juretschke2.   

Abstract

The number of multi-resistant uropathogens is increasing. A multi-morbid patient developed a symptomatic urinary tract infection with two multi-resistant bacteria, namely Klebsiella pneumoniae and Proteus mirabilis. Nitroxoline was the only drug active against both uropathogens. Obviously, nitroxoline can be an option for the therapy of a urinary tract infection with multi-resistant uropathogens.

Entities:  

Keywords:  Multi-resistant uropathogens; Nitroxoline; Urinary tract infections

Mesh：

Substances：

Year:  2018        PMID： 30449013     DOI： 10.1007/s15010-018-1253-y

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  15 in total

Review 1.  Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria.

Authors:  Ann Pallett; Kieran Hand
Journal:  J Antimicrob Chemother       Date:  2010-11       Impact factor: 5.790

2.  Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Francesco Giuseppe De Rosa; Maddalena Giannella; Daniele Roberto Giacobbe; Matteo Bassetti; Angela Raffaella Losito; Michele Bartoletti; Valerio Del Bono; Silvia Corcione; Giuseppe Maiuro; Sara Tedeschi; Luigi Celani; Chiara Simona Cardellino; Teresa Spanu; Anna Marchese; Simone Ambretti; Roberto Cauda; Claudio Viscoli; Pierluigi Viale
Journal:  J Antimicrob Chemother       Date:  2015-04-21       Impact factor: 5.790

3.  Evolution of antibiotic multiresistance in Escherichia coli and Klebsiella pneumoniae isolates from urinary tract infections: A 12-year analysis (2003-2014).

Authors:  David M Arana; Margarita Rubio; Juan-Ignacio Alós
Journal:  Enferm Infecc Microbiol Clin       Date:  2016-04-05       Impact factor: 1.731

4.  Healthcare-associated urinary tract infections in hospitalized urological patients--a global perspective: results from the GPIU studies 2003-2010.

Authors:  Mete Cek; Zafer Tandoğdu; Florian Wagenlehner; Peter Tenke; Kurt Naber; Truls Erik Bjerklund-Johansen
Journal:  World J Urol       Date:  2014-01-23       Impact factor: 4.226

Review 5.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

6.  [Candiduria! What now? : Therapy of urinary tract infections with Candida].

Authors:  H Hof
Journal:  Urologe A       Date:  2017-02       Impact factor: 0.639

7.  [Nitroxoline - an option for the antibiotic treatment of urinary tract infections].

Authors:  H Hof; D Bertsch; D Passek; R Schwarz
Journal:  Urologe A       Date:  2017-02       Impact factor: 0.639

8.  Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers.

Authors:  Florian M E Wagenlehner; Fabian Münch; Adrian Pilatz; Birte Bärmann; Wolfgang Weidner; Christine M Wagenlehner; Marion Straubinger; Holger Blenk; Wolfgang Pfister; Michael Kresken; Kurt G Naber
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

9.  The urinary antibiotic 5-nitro-8-hydroxyquinoline (Nitroxoline) reduces the formation and induces the dispersal of Pseudomonas aeruginosa biofilms by chelation of iron and zinc.

Authors:  A Sobke; M Klinger; B Hermann; S Sachse; S Nietzsche; O Makarewicz; P M Keller; W Pfister; E Straube
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

Review 10.  Review of the literature and individual patients' data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections.

Authors:  Kurt G Naber; Hiltrud Niggemann; Gisela Stein; Guenter Stein
Journal:  BMC Infect Dis       Date:  2014-11-27       Impact factor: 3.090
View more
  3 in total

Review 1.  Antimicrobial activity of clioquinol and nitroxoline: a scoping review.

Authors:  Rachel Wykowski; Alexandre Meneghello Fuentefria; Saulo Fernandes de Andrade
Journal:  Arch Microbiol       Date:  2022-07-30       Impact factor: 2.667

Review 2.  Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond.

Authors:  Davorka Repac Antić; Marijo Parčina; Ivana Gobin; Mirna Petković Didović
Journal:  Antibiotics (Basel)       Date:  2022-08-15

3.  Compared with Cotrimoxazole Nitroxoline Seems to Be a Better Option for the Treatment and Prophylaxis of Urinary Tract Infections Caused by Multidrug-Resistant Uropathogens: An In Vitro Study.

Authors:  Ulrich Dobrindt; Haleluya T Wami; Torsten Schmidt-Wieland; Daniela Bertsch; Klaus Oberdorfer; Herbert Hof
Journal:  Antibiotics (Basel)       Date:  2021-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.